6533b831fe1ef96bd1298cda

RESEARCH PRODUCT

Use of primary and secondary pegfilgrastim prophylaxis for reducing incidence of neutropenia: Findings from a large study in German clinical practice (PROTECT)

Martina SchmidtB. OtrembaH. EschenburgM. GeberthC.m. KurbacherP. Ramdohr

subject

medicine.medical_specialtybusiness.industryIncidence (epidemiology)HematologyNeutropeniamedicine.diseaselanguage.human_languageClinical PracticeGermanOncologyLarge studymedicinelanguageIntensive care medicinebusinessPegfilgrastimmedicine.drughttps://doi.org/10.1093/annonc/mdy300.018